Global Budesonide Market Insights and Forecast to 2027

Publisher Name :
Date: 04-May-2021
No. of pages: 119
Inquire Before Buying

Budesonide market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Budesonide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type

- Injectable Suspension

- Aerosols

- Inhalation Powder

- Tablet and Capsule

Segment by Application

- Respiratory Disease Treatment

- Nose Disease Treatment

- Inflammatory Bowel Disease Treatment

- Others

By Company

- AstraZeneca

- Teva

- Mylan

- Sandoz

- Cosmo Pharmaceuticals

- Salix

- Chiesi Farmaceutici

- Orion Corporation

- Cipla

- Synmosa Biopharma

- Lunan Better Pharma

- Shanghai Sine Promod

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

Global Budesonide Market Insights and Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Budesonide Product Introduction
1.2 Market by Type
1.2.1 Global Budesonide Market Size Growth Rate by Type
1.4.2 Injectable Suspension
1.4.3 Aerosols
1.2.4 Inhalation Powder
1.2.5 Tablet and Capsule
1.3 Market by Application
1.3.1 Global Budesonide Market Size Growth Rate by Application
1.3.2 Respiratory Disease Treatment
1.3.3 Nose Disease Treatment
1.3.4 Inflammatory Bowel Disease Treatment
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Budesonide Sales Estimates and Forecasts 2016-2027
2.2 Global Budesonide Revenue Estimates and Forecasts 2016-2027
2.3 Global Budesonide Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Budesonide Regions by Sales
2.4.1 Global Top Budesonide Regions by Sales (2016-2021)
2.4.2 Global Top Budesonide Regions by Sales (2022-2027)
2.5 Global Top Budesonide Regions by Revenue
2.5.1 Global Top Budesonide Regions by Revenue (2016-2021)
2.5.2 Global Top Budesonide Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Budesonide Sales by Manufacturers
3.1.1 Global Top Budesonide Manufacturers by Sales (2016-2021)
3.1.2 Global Top Budesonide Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Budesonide Sales in 2020
3.2 Global Budesonide Revenue by Manufacturers
3.2.1 Global Top Budesonide Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Budesonide Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Budesonide Revenue in 2020
3.3 Global Budesonide Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Budesonide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Budesonide Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Budesonide Sales by Type
4.1.1 Global Budesonide Historical Sales by Type (2016-2021)
4.1.2 Global Budesonide Forecasted Sales by Type (2022-2027)
4.1.3 Global Budesonide Sales Market Share by Type (2016-2027)
4.2 Global Budesonide Revenue by Type
4.2.1 Global Budesonide Historical Revenue by Type (2016-2021)
4.2.2 Global Budesonide Forecasted Revenue by Type (2022-2027)
4.2.3 Global Budesonide Revenue Market Share by Type (2016-2027)
4.3 Global Budesonide Price by Type
4.3.1 Global Budesonide Price by Type (2016-2021)
4.3.2 Global Budesonide Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Budesonide Sales by Application
5.1.1 Global Budesonide Historical Sales by Application (2016-2021)
5.1.2 Global Budesonide Forecasted Sales by Application (2022-2027)
5.1.3 Global Budesonide Sales Market Share by Application (2016-2027)
5.2 Global Budesonide Revenue by Application
5.2.1 Global Budesonide Historical Revenue by Application (2016-2021)
5.2.2 Global Budesonide Forecasted Revenue by Application (2022-2027)
5.2.3 Global Budesonide Revenue Market Share by Application (2016-2027)
5.3 Global Budesonide Price by Application
5.3.1 Global Budesonide Price by Application (2016-2021)
5.3.2 Global Budesonide Price Forecast by Application (2022-2027)
6 North America
6.1 North America Budesonide Market Size by Type
6.1.1 North America Budesonide Sales by Type (2016-2027)
6.1.2 North America Budesonide Revenue by Type (2016-2027)
6.2 North America Budesonide Market Size by Application
6.2.1 North America Budesonide Sales by Application (2016-2027)
6.2.2 North America Budesonide Revenue by Application (2016-2027)
6.3 North America Budesonide Market Size by Country
6.3.1 North America Budesonide Sales by Country (2016-2027)
6.3.2 North America Budesonide Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Budesonide Market Size by Type
7.1.1 Europe Budesonide Sales by Type (2017-2027)
7.1.2 Europe Budesonide Revenue by Type (2017-2027)
7.2 Europe Budesonide Market Size by Application
7.2.1 Europe Budesonide Sales by Application (2017-2027)
7.2.2 Europe Budesonide Revenue by Application (2017-2027)
7.3 Europe Budesonide Market Size by Country
7.3.1 Europe Budesonide Sales by Country (2017-2027)
7.3.2 Europe Budesonide Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Budesonide Market Size by Type
8.1.1 Asia Pacific Budesonide Sales by Type (2018-2027)
8.1.2 Asia Pacific Budesonide Revenue by Type (2018-2027)
8.2 Asia Pacific Budesonide Market Size by Application
8.2.1 Asia Pacific Budesonide Sales by Application (2018-2027)
8.2.2 Asia Pacific Budesonide Revenue by Application (2018-2027)
8.3 Asia Pacific Budesonide Market Size by Region
8.3.1 Asia Pacific Budesonide Sales by Region (2018-2027)
8.3.2 Asia Pacific Budesonide Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Budesonide Market Size by Type
9.1.1 Latin America Budesonide Sales by Type (2019-2027)
9.1.2 Latin America Budesonide Revenue by Type (2019-2027)
9.2 Latin America Budesonide Market Size by Application
9.2.1 Latin America Budesonide Sales by Application (2019-2027)
9.2.2 Latin America Budesonide Revenue by Application (2019-2027)
9.3 Latin America Budesonide Market Size by Country
9.3.1 Latin America Budesonide Sales by Country (2019-2027)
9.3.2 Latin America Budesonide Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
6 Middle East and Africa
6.1 Middle East and Africa Budesonide Market Size by Type
6.1.1 Middle East and Africa Budesonide Sales by Type (2016-2027)
6.1.2 Middle East and Africa Budesonide Revenue by Type (2016-2027)
6.2 Middle East and Africa Budesonide Market Size by Application
6.2.1 Middle East and Africa Budesonide Sales by Application (2016-2027)
6.2.2 Middle East and Africa Budesonide Revenue by Application (2016-2027)
6.3 Middle East and Africa Budesonide Market Size by Country
6.3.1 Middle East and Africa Budesonide Sales by Country (2016-2027)
6.3.2 Middle East and Africa Budesonide Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 U.A.E
11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Overview
11.1.3 AstraZeneca Budesonide Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 AstraZeneca Budesonide Product Description
11.1.5 AstraZeneca Related Developments
11.2 Teva
11.2.1 Teva Corporation Information
11.2.2 Teva Overview
11.2.3 Teva Budesonide Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Teva Budesonide Product Description
11.2.5 Teva Related Developments
11.3 Mylan
11.3.1 Mylan Corporation Information
11.3.2 Mylan Overview
11.3.3 Mylan Budesonide Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Mylan Budesonide Product Description
11.3.5 Mylan Related Developments
11.4 Sandoz
11.4.1 Sandoz Corporation Information
11.4.2 Sandoz Overview
11.4.3 Sandoz Budesonide Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Sandoz Budesonide Product Description
11.4.5 Sandoz Related Developments
11.5 Cosmo Pharmaceuticals
11.5.1 Cosmo Pharmaceuticals Corporation Information
11.5.2 Cosmo Pharmaceuticals Overview
11.5.3 Cosmo Pharmaceuticals Budesonide Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Cosmo Pharmaceuticals Budesonide Product Description
11.5.5 Cosmo Pharmaceuticals Related Developments
11.6 Salix
11.6.1 Salix Corporation Information
11.6.2 Salix Overview
11.6.3 Salix Budesonide Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Salix Budesonide Product Description
11.6.5 Salix Related Developments
11.7 Chiesi Farmaceutici
11.7.1 Chiesi Farmaceutici Corporation Information
11.7.2 Chiesi Farmaceutici Overview
11.7.3 Chiesi Farmaceutici Budesonide Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Chiesi Farmaceutici Budesonide Product Description
11.7.5 Chiesi Farmaceutici Related Developments
11.8 Orion Corporation
11.8.1 Orion Corporation Corporation Information
11.8.2 Orion Corporation Overview
11.8.3 Orion Corporation Budesonide Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Orion Corporation Budesonide Product Description
11.8.5 Orion Corporation Related Developments
11.9 Cipla
11.9.1 Cipla Corporation Information
11.9.2 Cipla Overview
11.9.3 Cipla Budesonide Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Cipla Budesonide Product Description
11.9.5 Cipla Related Developments
11.10 Synmosa Biopharma
11.10.1 Synmosa Biopharma Corporation Information
11.10.2 Synmosa Biopharma Overview
11.10.3 Synmosa Biopharma Budesonide Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Synmosa Biopharma Budesonide Product Description
11.10.5 Synmosa Biopharma Related Developments
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Overview
11.1.3 AstraZeneca Budesonide Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 AstraZeneca Budesonide Product Description
11.1.5 AstraZeneca Related Developments
11.12 Shanghai Sine Promod
11.12.1 Shanghai Sine Promod Corporation Information
11.12.2 Shanghai Sine Promod Overview
11.12.3 Shanghai Sine Promod Budesonide Sales, Price, Revenue and Gross Margin (2016-2021)
11.12.4 Shanghai Sine Promod Product Description
11.12.5 Shanghai Sine Promod Related Developments
12 Value Chain and Sales Channels Analysis
12.1 Budesonide Value Chain Analysis
12.2 Budesonide Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Budesonide Production Mode & Process
12.4 Budesonide Sales and Marketing
12.4.1 Budesonide Sales Channels
12.4.2 Budesonide Distributors
12.5 Budesonide Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Budesonide Industry Trends
13.2 Budesonide Market Drivers
13.3 Budesonide Market Challenges
13.4 Budesonide Market Restraints
14 Key Findings in The Global Budesonide Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Budesonide Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Injectable Suspension
Table 3. Major Manufacturers of Aerosols
Table 4. Major Manufacturers of Inhalation Powder
Table 5. Major Manufacturers of Tablet and Capsule
Table 6. Global Budesonide Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 7. Global Budesonide Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 8. Global Budesonide Sales by Region (2016-2021) & (M Units)
Table 9. Global Budesonide Sales Market Share by Region (2016-2021)
Table 10. Global Budesonide Sales by Region (2016-2021) & (M Units)
Table 11. Global Budesonide Sales Market Share by Region (2022-2027)
Table 12. Global Budesonide Revenue by Region (2016-2021) & (US$ Million)
Table 13. Global Budesonide Revenue Market Share by Region (2016-2021)
Table 14. Global Budesonide Revenue by Region (2022-2027) & (US$ Million)
Table 15. Global Budesonide Revenue Market Share by Region (2022-2027)
Table 16. Global Budesonide Sales by Manufacturers (2016-2021) & (M Units)
Table 17. Global Budesonide Sales Share by Manufacturers (2016-2021)
Table 18. Global Budesonide Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 19. Global Budesonide Revenue Share by Manufacturers (2016-2021)
Table 20. Budesonide Price by Manufacturers 2016-2021 (US$/K Units)
Table 21. Global Budesonide Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Budesonide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Budesonide as of 2020)
Table 23. Budesonide Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Budesonide Product Offered
Table 25. Date of Manufacturers Enter into Budesonide Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Budesonide Sales by Type (2016-2021) & (M Units)
Table 28. Global Budesonide Sales by Type (2022-2027) & (M Units)
Table 29. Global Budesonide Sales Share by Type (2016-2021)
Table 30. Global Budesonide Sales Share by Type (2022-2027)
Table 31. Global Budesonide Revenue by Type (2016-2021) & (US$ Million)
Table 32. Global Budesonide Revenue by Type (2022-2027) & (US$ Million)
Table 33. Global Budesonide Revenue Share by Type (2016-2021)
Table 34. Global Budesonide Revenue Share by Type (2022-2027)
Table 35. Budesonide Price by Type (2016-2021) & (US$/K Units)
Table 36. Global Budesonide Price Forecast by Type (2022-2027) & (US$/K Units)
Table 37. Global Budesonide Sales by Application (2016-2021) & (M Units)
Table 38. Global Budesonide Sales by Application (2022-2027) & (M Units)
Table 39. Global Budesonide Sales Share by Application (2016-2021)
Table 40. Global Budesonide Sales Share by Application (2022-2027)
Table 41. Global Budesonide Revenue by Application (2016-2021) & (US$ Million)
Table 42. Global Budesonide Revenue by Application (2022-2027) & (US$ Million)
Table 43. Global Budesonide Revenue Share by Application (2016-2021)
Table 44. Global Budesonide Revenue Share by Application (2022-2027)
Table 45. Budesonide Price by Application (2016-2021) & (US$/K Units)
Table 46. Global Budesonide Price Forecast by Application (2022-2027) & (US$/K Units)
Table 47. North America Budesonide Sales by Type (2016-2021) & (M Units)
Table 48. North America Budesonide Sales by Type (2022-2027) & (M Units)
Table 49. North America Budesonide Revenue by Type (2016-2021) & (US$ Million)
Table 50. North America Budesonide Revenue by Type (2022-2027) & (US$ Million)
Table 51. North America Budesonide Sales by Application (2016-2021) & (M Units)
Table 52. North America Budesonide Sales by Application (2022-2027) & (M Units)
Table 53. North America Budesonide Revenue by Application (2016-2021) & (US$ Million)
Table 54. North America Budesonide Revenue by Application (2022-2027) & (US$ Million)
Table 55. North America Budesonide Sales by Country (2016-2021) & (M Units)
Table 56. North America Budesonide Sales by Country (2022-2027) & (M Units)
Table 57. North America Budesonide Revenue by Country (2016-2021) & (US$ Million)
Table 58. North America Budesonide Revenue by Country (2022-2027) & (US$ Million)
Table 59. Europe Budesonide Sales by Type (2016-2021) & (M Units)
Table 60. Europe Budesonide Sales by Type (2022-2027) & (M Units)
Table 61. Europe Budesonide Revenue by Type (2016-2021) & (US$ Million)
Table 62. Europe Budesonide Revenue by Type (2022-2027) & (US$ Million)
Table 63. Europe Budesonide Sales by Application (2016-2021) & (M Units)
Table 64. Europe Budesonide Sales by Application (2022-2027) & (M Units)
Table 65. Europe Budesonide Revenue by Application (2016-2021) & (US$ Million)
Table 66. Europe Budesonide Revenue by Application (2022-2027) & (US$ Million)
Table 67. Europe Budesonide Sales by Country (2016-2021) & (M Units)
Table 68. Europe Budesonide Sales by Country (2022-2027) & (M Units)
Table 69. Europe Budesonide Revenue by Country (2016-2021) & (US$ Million)
Table 70. Europe Budesonide Revenue by Country (2022-2027) & (US$ Million)
Table 71. Asia Pacific Budesonide Sales by Type (2016-2021) & (M Units)
Table 72. Asia Pacific Budesonide Sales by Type (2022-2027) & (M Units)
Table 73. Asia Pacific Budesonide Revenue by Type (2016-2021) & (US$ Million)
Table 74. Asia Pacific Budesonide Revenue by Type (2022-2027) & (US$ Million)
Table 75. Asia Pacific Budesonide Sales by Application (2016-2021) & (M Units)
Table 76. Asia Pacific Budesonide Sales by Application (2022-2027) & (M Units)
Table 77. Asia Pacific Budesonide Revenue by Application (2016-2021) & (US$ Million)
Table 78. Asia Pacific Budesonide Revenue by Application (2022-2027) & (US$ Million)
Table 79. Asia Pacific Budesonide Sales by Region (2016-2021) & (M Units)
Table 80. Asia Pacific Budesonide Sales by Region (2022-2027) & (M Units)
Table 81. Asia Pacific Budesonide Revenue by Region (2016-2021) & (US$ Million)
Table 82. Asia Pacific Budesonide Revenue by Region (2022-2027) & (US$ Million)
Table 83. Latin America Budesonide Sales by Type (2016-2021) & (M Units)
Table 84. Latin America Budesonide Sales by Type (2022-2027) & (M Units)
Table 85. Latin America Budesonide Revenue by Type (2016-2021) & (US$ Million)
Table 86. Latin America Budesonide Revenue by Type (2022-2027) & (US$ Million)
Table 87. Latin America Budesonide Sales by Application (2016-2021) & (M Units)
Table 88. Latin America Budesonide Sales by Application (2022-2027) & (M Units)
Table 89. Latin America Budesonide Revenue by Application (2016-2021) & (US$ Million)
Table 90. Latin America Budesonide Revenue by Application (2022-2027) & (US$ Million)
Table 91. Latin America Budesonide Sales by Country (2016-2021) & (M Units)
Table 92. Latin America Budesonide Sales by Country (2022-2027) & (M Units)
Table 93. Latin America Budesonide Revenue by Country (2016-2021) & (US$ Million)
Table 94. Latin America Budesonide Revenue by Country (2022-2027) & (US$ Million)
Table 95. Middle East and Africa Budesonide Sales by Type (2016-2021) & (M Units)
Table 96. Middle East and Africa Budesonide Sales by Type (2022-2027) & (M Units)
Table 97. Middle East and Africa Budesonide Revenue by Type (2016-2021) & (US$ Million)
Table 98. Middle East and Africa Budesonide Revenue by Type (2022-2027) & (US$ Million)
Table 99. Middle East and Africa Budesonide Sales by Application (2016-2021) & (M Units)
Table 100. Middle East and Africa Budesonide Sales by Application (2022-2027) & (M Units)
Table 101. Middle East and Africa Budesonide Revenue by Application (2016-2021) & (US$ Million)
Table 102. Middle East and Africa Budesonide Revenue by Application (2022-2027) & (US$ Million)
Table 103. Middle East and Africa Budesonide Sales by Country (2016-2021) & (M Units)
Table 104. Middle East and Africa Budesonide Sales by Country (2022-2027) & (M Units)
Table 105. Middle East and Africa Budesonide Revenue by Country (2016-2021) & (US$ Million)
Table 106. Middle East and Africa Budesonide Revenue by Country (2022-2027) & (US$ Million)
Table 107. AstraZeneca Corporation Information
Table 108. AstraZeneca Description and Major Businesses
Table 109. AstraZeneca Budesonide Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2016-2021)
Table 110. AstraZeneca Budesonide Product
Table 111. AstraZeneca Recent Developments
Table 112. Teva Corporation Information
Table 113. Teva Description and Major Businesses
Table 114. Teva Budesonide Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2016-2021)
Table 115. Teva Budesonide Product
Table 116. Teva Recent Developments
Table 117. Mylan Corporation Information
Table 118. Mylan Description and Major Businesses
Table 119. Mylan Budesonide Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2016-2021)
Table 120. Mylan Budesonide Product
Table 121. Mylan Recent Developments
Table 122. Sandoz Corporation Information
Table 123. Sandoz Description and Major Businesses
Table 124. Sandoz Budesonide Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2016-2021)
Table 125. Sandoz Budesonide Product
Table 126. Sandoz Recent Developments
Table 127. Cosmo Pharmaceuticals Corporation Information
Table 128. Cosmo Pharmaceuticals Description and Major Businesses
Table 129. Cosmo Pharmaceuticals Budesonide Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2016-2021)
Table 130. Cosmo Pharmaceuticals Budesonide Product
Table 131. Cosmo Pharmaceuticals Recent Developments
Table 132. Salix Corporation Information
Table 133. Salix Description and Major Businesses
Table 134. Salix Budesonide Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2016-2021)
Table 135. Salix Budesonide Product
Table 136. Salix Recent Developments
Table 137. Chiesi Farmaceutici Corporation Information
Table 138. Chiesi Farmaceutici Description and Major Businesses
Table 139. Chiesi Farmaceutici Budesonide Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2016-2021)
Table 140. Chiesi Farmaceutici Budesonide Product
Table 141. Chiesi Farmaceutici Recent Developments
Table 142. Orion Corporation Corporation Information
Table 143. Orion Corporation Description and Major Businesses
Table 144. Orion Corporation Budesonide Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2016-2021)
Table 145. Orion Corporation Budesonide Product
Table 146. Orion Corporation Recent Developments
Table 147. Cipla Corporation Information
Table 148. Cipla Description and Major Businesses
Table 149. Cipla Budesonide Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2016-2021)
Table 150. Cipla Budesonide Product
Table 151. Cipla Recent Developments
Table 152. Synmosa Biopharma Corporation Information
Table 153. Synmosa Biopharma Description and Major Businesses
Table 154. Synmosa Biopharma Budesonide Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2016-2021)
Table 155. Synmosa Biopharma Budesonide Product
Table 156. Synmosa Biopharma Recent Developments
Table 157. Lunan Better Pharma Corporation Information
Table 158. Lunan Better Pharma Description and Major Businesses
Table 159. Lunan Better Pharma Budesonide Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2016-2021)
Table 160. Lunan Better Pharma Budesonide Product
Table 161. Lunan Better Pharma Recent Developments
Table 162. Shanghai Sine Promod Corporation Information
Table 163. Shanghai Sine Promod Description and Major Businesses
Table 164. Shanghai Sine Promod Budesonide Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2016-2021)
Table 165. Shanghai Sine Promod Budesonide Product
Table 166. Shanghai Sine Promod Recent Developments
Table 167. Key Raw Materials Lists
Table 168. Raw Materials Key Suppliers Lists
Table 169. Budesonide Distributors List
Table 170. Budesonide Customers List
Table 171. Budesonide Market Trends
Table 172. Budesonide Market Drivers
Table 173. Budesonide Market Challenges
Table 174. Budesonide Market Restraints
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Budesonide Product Picture
Figure 2. Global Budesonide Market Share by Type in 2020 & 2027
Figure 3. Injectable Suspension Product Picture
Figure 4. Aerosols Product Picture
Figure 5. Inhalation Powder Product Picture
Figure 6. Tablet and Capsule Product Picture
Figure 7. Global Budesonide Sales Market Share by Application in 2020 & 2027
Figure 8. Respiratory Disease Treatment
Figure 9. Nose Disease Treatment
Figure 10. Inflammatory Bowel Disease Treatment
Figure 11. Others
Figure 12. Budesonide Report Years Considered
Figure 13. Global Budesonide Sales 2016-2027 (M Units)
Figure 14. Global Budesonide Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Budesonide Revenue 2016-2027 (US$ Million)
Figure 16. Global Budesonide Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 17. Global Budesonide Sales Market Share by Region (2016-2021)
Figure 18. Global Budesonide Sales Market Share by Region (2022-2027)
Figure 19. North America Budesonide Sales YoY (2016-2027) & (M Units)
Figure 20. North America Budesonide Revenue YoY (2016-2027) & (US$ Million)
Figure 21. Europe Budesonide Sales YoY (2016-2027) & (M Units)
Figure 22. Europe Budesonide Revenue YoY (2016-2027) & (US$ Million)
Figure 23. Asia-Pacific Budesonide Sales YoY (2016-2027) & (M Units)
Figure 24. Asia-Pacific Budesonide Revenue YoY (2016-2027) & (US$ Million)
Figure 25. Latin America Budesonide Sales YoY (2016-2027) & (M Units)
Figure 26. Latin America Budesonide Revenue YoY (2016-2027) & (US$ Million)
Figure 27. Middle East & Africa Budesonide Sales YoY (2016-2027) & (M Units)
Figure 28. Middle East & Africa Budesonide Revenue YoY (2016-2027) & (US$ Million)
Figure 29. The Top 10 and Top 5 Players Market Share by Budesonide Sales in 2020
Figure 30. The Top 10 and Top 5 Players Market Share by Budesonide Revenue in 2020
Figure 31. Budesonide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 32. Global Budesonide Sales Market Share by Type (2016-2027)
Figure 33. Global Budesonide Revenue Market Share by Type (2016-2027)
Figure 34. Global Budesonide Sales Market Share by Application (2016-2027)
Figure 35. Global Budesonide Revenue Market Share by Application (2016-2027)
Figure 36. North America Budesonide Sales Market Share by Type (2016-2027)
Figure 37. North America Budesonide Revenue Market Share by Type (2016-2027)
Figure 38. North America Budesonide Sales Market Share by Application (2016-2027)
Figure 39. North America Budesonide Revenue Market Share by Application (2016-2027)
Figure 40. North America Budesonide Sales Share by Country (2016-2027)
Figure 41. North America Budesonide Revenue Share by Country (2016-2027)
Figure 42. U.S. Budesonide Revenue (2016-2027) & (US$ Million)
Figure 43. Canada Budesonide Revenue (2016-2027) & (US$ Million)
Figure 44. Europe Budesonide Sales Market Share by Type (2016-2027)
Figure 45. Europe Budesonide Revenue Market Share by Type (2016-2027)
Figure 46. Europe Budesonide Sales Market Share by Application (2016-2027)
Figure 47. Europe Budesonide Revenue Market Share by Application (2016-2027)
Figure 48. Europe Budesonide Sales Share by Country (2016-2027)
Figure 49. Europe Budesonide Revenue Share by Country (2016-2027)
Figure 50. Germany Budesonide Revenue (2016-2027) & (US$ Million)
Figure 51. France Budesonide Revenue (2016-2027) & (US$ Million)
Figure 52. U.K. Budesonide Revenue (2016-2027) & (US$ Million)
Figure 53. Italy Budesonide Revenue (2016-2027) & (US$ Million)
Figure 54. Russia Budesonide Revenue (2016-2027) & (US$ Million)
Figure 55. Asia Pacific Budesonide Sales Market Share by Type (2016-2027)
Figure 56. Asia Pacific Budesonide Revenue Market Share by Type (2016-2027)
Figure 57. Asia Pacific Budesonide Sales Market Share by Application (2016-2027)
Figure 58. Asia Pacific Budesonide Revenue Market Share by Application (2016-2027)
Figure 59. Asia Pacific Budesonide Sales Share by Region (2016-2027)
Figure 60. Asia Pacific Budesonide Revenue Share by Region (2016-2027)
Figure 61. China Budesonide Revenue (2016-2027) & (US$ Million)
Figure 62. Japan Budesonide Revenue (2016-2027) & (US$ Million)
Figure 63. South Korea Budesonide Revenue (2016-2027) & (US$ Million)
Figure 64. India Budesonide Revenue (2016-2027) & (US$ Million)
Figure 65. Australia Budesonide Revenue (2016-2027) & (US$ Million)
Figure 66. Taiwan Budesonide Revenue (2016-2027) & (US$ Million)
Figure 67. Indonesia Budesonide Revenue (2016-2027) & (US$ Million)
Figure 68. Thailand Budesonide Revenue (2016-2027) & (US$ Million)
Figure 69. Malaysia Budesonide Revenue (2016-2027) & (US$ Million)
Figure 70. Philippines Budesonide Revenue (2016-2027) & (US$ Million)
Figure 71. Latin America Budesonide Sales Market Share by Type (2016-2027)
Figure 72. Latin America Budesonide Revenue Market Share by Type (2016-2027)
Figure 73. Latin America Budesonide Sales Market Share by Application (2016-2027)
Figure 74. Latin America Budesonide Revenue Market Share by Application (2016-2027)
Figure 75. Latin America Budesonide Sales Share by Country (2016-2027)
Figure 76. Latin America Budesonide Revenue Share by Country (2016-2027)
Figure 77. Mexico Budesonide Revenue (2016-2027) & (US$ Million)
Figure 78. Brazil Budesonide Revenue (2016-2027) & (US$ Million)
Figure 79. Argentina Budesonide Revenue (2016-2027) & (US$ Million)
Figure 80. Middle East and Africa Budesonide Sales Market Share by Type (2016-2027)
Figure 81. Middle East and Africa Budesonide Revenue Market Share by Type (2016-2027)
Figure 82. Middle East and Africa Budesonide Sales Market Share by Application (2016-2027)
Figure 83. Middle East and Africa Budesonide Revenue Market Share by Application (2016-2027)
Figure 84. Middle East and Africa Budesonide Sales Share by Country (2016-2027)
Figure 85. Middle East and Africa Budesonide Revenue Share by Country (2016-2027)
Figure 86. Turkey Budesonide Revenue (2016-2027) & (US$ Million)
Figure 87. Saudi Arabia Budesonide Revenue (2016-2027) & (US$ Million)
Figure 88. U.A.E Budesonide Revenue (2016-2027) & (US$ Million)
Figure 89. Budesonide Value Chain
Figure 90. Budesonide Production Process
Figure 91. Channels of Distribution
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed
  • Global Acepromazine Sales Market Report 2021
    Published: 07-May-2021        Price: US 4000 Onwards        Pages: 136
    The global Acepromazine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Acepromazine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Powder - Liquid - Crystal - Others......
  • Global Phenylketonuria (PKU) Market Insights and Forecast to 2027
    Published: 07-May-2021        Price: US 4900 Onwards        Pages: 110
    Phenylketonuria (PKU) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Phenylketonuria (PKU) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027. Segment by Type - Medications - Supplements - Others Segment by Application - Househ......
  • Global Oral Proteins and Peptides Sales Market Report 2021
    Published: 06-May-2021        Price: US 4000 Onwards        Pages: 128
    The global Oral Proteins and Peptides market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Oral Proteins and Peptides market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Linaclotide - Calcitoni......
  • Global Varicella Attenuated Live Vaccine Market Insights and Forecast to 2027
    Published: 06-May-2021        Price: US 4900 Onwards        Pages: 115
    Varicella Attenuated Live Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Varicella Attenuated Live Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027. Segment by Type - Monovalent Vaccine - Combination Vaccine Segment by Appl......
  • Global PVP Iodine Market Insights and Forecast to 2027
    Published: 06-May-2021        Price: US 4900 Onwards        Pages: 114
    PVP Iodine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global PVP Iodine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027. Segment by Type - Medical Grade PVP Iodine - Industrial Grade PVP Iodine Segment by Application - Medical Use......
  • Global Omeprazole Sales Market Report 2021
    Published: 05-May-2021        Price: US 4000 Onwards        Pages: 134
    The global Omeprazole market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Omeprazole market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Capsule - Tablet - Injection Segm......
  • Global Eliquis Sales Market Report 2021
    Published: 05-May-2021        Price: US 4000 Onwards        Pages: 114
    The global Eliquis market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Eliquis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - 2.5 mg - 5 mg Segment by Application - ......
  • Global Self-administered Drugs Sales Market Report 2021
    Published: 05-May-2021        Price: US 4000 Onwards        Pages: 117
    The global Self-administered Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Self-administered Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Injectable Drugs - Inhaled Dr......
  • Global Tetanus Vaccine Sales Market Report 2021
    Published: 04-May-2021        Price: US 4000 Onwards        Pages: 121
    The global Tetanus Vaccine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Tetanus Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Diphtheria and tetanus (DT) vaccines - Diphth......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs